REGIONAL DIFFERENCES IN PROSTACYCLIN FORMATION BY KIDNEY - PROSTACYCLIN IS A MAJOR PROSTAGLANDIN OF RENAL CORTEX

被引：152

作者：

WHORTON, AR ^{[1
]}

SMIGEL, M ^{[1
]}

OATES, JA ^{[1
]}

FROLICH, JC ^{[1
]}

机构：

[1] VANDERBILT UNIV,DEPT MED,NASHVILLE,TN 37232

来源：

BIOCHIMICA ET BIOPHYSICA ACTA | 1978年 / 529卷 / 01期

关键词：

D O I：

10.1016/0005-2760(78)90116-9

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：176 / 180

页数：5

共 50 条

[31] TRANSFORMATION OF ARACHIDONIC-ACID AND PROSTAGLANDIN ENDOPEROXIDES BY GUINEA-PIG HEART - FORMATION OF RCS AND PROSTACYCLIN
SCHROR, K
MONCADA, S
UBATUBA, FB
VANE, JR
EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 47 (01) : 103 - 114
[32] IMMUNOHISTOCHEMICAL DISTRIBUTION OF RENAL PROSTAGLANDIN ENDOPEROXIDE SYNTHASE AND PROSTACYCLIN SYNTHASE - DIMINISHED ENDOPEROXIDE SYNTHASE IN THE HEPATORENAL-SYNDROME
GOVINDARAJAN, S
NAST, CC
SMITH, WL
KOYLE, MA
DASKALOPOULOS, G
ZIPSER, RD
HEPATOLOGY, 1987, 7 (04) : 654 - 659
[33] 6-KETO-PROSTAGLANDIN-E1 - ITS FORMATION BY PLATELETS FROM PROSTACYCLIN AND RESISTANCE TO PULMONARY DEGRADATION
BERRY, CN
HOULT, JRS
PHARMACOLOGY, 1983, 26 (06) : 324 - 330
[34] PROSTACYCLIN, THROMBOXANE-A2, AND PROSTAGLANDIN-E2 FORMATION IN ATHEROSCLEROTIC HUMAN CAROTID-ARTERY
RUSH, DS
KERSTEIN, MD
BELLAN, JA
KNOOP, SM
MAYEUX, PR
HYMAN, AL
KADOWITZ, PJ
MCNAMARA, DB
ARTERIOSCLEROSIS, 1988, 8 (01): : 73 - 78
[35] The role of a novel kidney-specific prostaglandin transporter in the local prostaglandin clearance in renal cortex
Kanai, Yoshikatsu
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 23P - 23P
[36] A COMPARISON OF THE EFFECTS OF PROSTACYCLIN AND 6-KETO-PROSTAGLANDIN-E1 ON RENIN RELEASE IN THE ISOLATED RAT AND RABBIT KIDNEY
SCHWERTSCHLAG, U
STAHL, T
HACKENTHAL, E
PROSTAGLANDINS, 1982, 23 (01): : 129 - 138
[37] REGIONAL DIFFERENCES IN 6-KETO PROSTAGLANDIN-F1-ALPHA FORMATION BY DOG KIDNEY MICROSOMES
SATOH, H
SATOH, S
FOLIA PHARMACOLOGICA JAPONICA, 1980, 76 (02) : P52 - P52
[38] PROSTACYCLIN (PGI2) PRODUCTION BY RENAL BLOOD-VESSELS - RELATIONSHIP TO AN ENDOGENOUS PROSTAGLANDIN SYNTHESIS INHIBITOR (EPSI)
TERRAGNO, NA
MCGIFF, JC
TERRAGNO, A
CLINICAL RESEARCH, 1978, 26 (03): : A545 - A545
[39] IS THE VARIATION IN THE SUSCEPTIBILITY OF VARIOUS SPECIES TO ATHEROSCLEROSIS DUE TO INBORN DIFFERENCES IN PROSTACYCLIN (PGI2) FORMATION
SINZINGER, H
CLOPATH, P
SILBERBAUER, K
WINTER, M
EXPERIENTIA, 1980, 36 (03): : 321 - 323
[40] DECREASED SYSTEMIC FORMATION OF PROSTAGLANDIN-E AND PROSTACYCLIN, AND UNCHANGED THROMBOXANE FORMATION, IN ALCOHOLICS DURING WITHDRAWAL AS ESTIMATED FROM METABOLITES IN URINE
FORSTERMANN, U
FEUERSTEIN, TJ
CLINICAL SCIENCE, 1987, 73 (03) : 277 - 283

← 1 2 3 4 5 →